A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 130.28
GOOG 565.06
MSFT 47.87
FB 81.53
BAC 15.64

Recently Added

WCIC 24.13
VCRA 11.55
P 18.37
PPHM 1.39
BUD 123.72

Gaining Speed

ESS 227.01
ZMH 118.76
P 18.37
THC 50.65
VCRA 11.55

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More

Get Alerted When News Hits On This Stock - FREE!